NEW YORK, December 31, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Analysts' Corner announced new research reports highlighting Life Technologies Corporation (NASDAQ: LIFE), Covance Inc. (NYSE: CVD), HB Fuller Co. (NYSE: FUL), Solta Medical, Inc. (NASDAQ: SLTM), and NuPathe, Inc. (NASDAQ: PATH). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Life Technologies Corporation Research Report

On December 20, 2013, Life Technologies Corporation (Life Technologies) announced that Cynvenio Biosystems, a molecular testing company focused on liquid biopsy assay development, has joined the Company's Ion Certified Service Provider (CSP) program. The Company reported that Cynvenio's LiquidBiopsy technology is a proprietary platform for recovering circulating tumor cells at purity levels high enough to enable detection by next-generation sequencing. According to Life Technologies, in addition to providing research-use-only (RUO) services under the Ion CSP program, Cynvenio has several development programs supported by the National Cancer Institute, which are focused on finding cancer biomarkers in the blood. Life Technologies informed that the said programs are aimed at developing fast, non-invasive methods for detecting and managing breast cancer and other adenocarcinomas (solid tumors). The Full Research Report on Life Technologies Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/d5de_LIFE

Covance Inc. Research Report

On December 19, 2013, Covance Inc.'s (Covance) Board of Directors has authorized the repurchase of up to $100 million of its outstanding common stock. Covance reported that any purchases under this buyback would be dependent upon business and market conditions and other factors. Covance informed that stock purchases may be made from time to time and may be made through a variety of methods including open market purchases, privately negotiated transactions, block trades, and 10b5-1 plans. The Full Research Report on Covance Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/5691_CVD

HB Fuller Co. Research Report

On December 26, 2013, HB Fuller Co.'s (HB Fuller) stock declined 0.65%, and closed the day at $50.69. Over the previous three trading sessions, shares of HB Fuller increased 0.04%, compared to the Dow Jones industrial average which increased 1.60% during the same period. The Full Research Report on HB Fuller Co. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/6b73_FUL

Solta Medical, Inc. Research Report

On December 26, 2013, Solta Medical, Inc.'s (Solta Medical) stock rose 0.34%, and closed the day at $2.98. Over the previous three trading sessions, shares of Solta Medical increased 0.68%, compared to the Nasdaq Composite which increased 1.52% during the same period. The Full Research Report on Solta Medical, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/c5ec_SLTM

NuPathe, Inc. Research Report

On December 26, 2013, NuPathe, Inc.'s (NuPathe) stock rose 0.30% to $3.31. Over the previous three trading sessions, shares of NuPathe increased 2.16%, compared to the Nasdaq Composite which increased 1.52% during the same period. The Full Research Report on NuPathe, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/d5b0_PATH

EDITOR NOTES: 


        
        1) This is not company news. We are an independent source and our views do
          not reflect the companies mentioned.
        2) Information in this release is fact checked and produced on a best efforts
          basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human
          and are prone to make mistakes. If you notice any errors or omissions, please notify
          us below.
        3) This information is submitted as a net-positive to companies mentioned, to
          increase awareness for mentioned companies to our subscriber base and the investing
          public.
        4) If you wish to have your company covered in more detail by our team, or wish
          to learn more about our services, please contact us at
          pubco@EquityNewsNetwork.com.
        5) For any urgent concerns or inquiries, please contact us at
          compliance@EquityNewsNetwork.com.
        6) Are you a public company? Would you like to see similar coverage on your
          company? Send us a full investors' package to research@EquityNewsNetwork.com for
          consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

http://www.analystscorner.com

SOURCE Analysts' Corner